Eurogin is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
A full overview of current scientific developments in the field of cervical cancer and other HPV related diseases
EUROGIN focuses on translating scientific and evidence-based research into clinical practice by offering a high quality and innovative scientific program drawn up by outstanding international leaders from the academic sector as well as professional and patient organizations.
The program aims to foster future advancements by providing fundamental insights to physicians and young researchers.
The EUROGIN HPV and Head & Neck Cancer Forum will highlight recent advances and areas of active research in the field of HPV-related head and neck cancers.
This workshop will provide more insight into the transition from research to implementation on the basis of 3 potential new screening technologies on the roadmap to eliminate cervical cancer: HPV-screening, self-sampling and methylation.
Élimination du cancer du col utérin en marche
Comment la France peut parvenir à une stratégie nationale d’élimination des cancers HPV-induits ?
For the 2023 edition of EUROGIN, we have a half-day local workshop, in Spanish, conducted in association with “Asociación Española de Patología Cervical y Colposcopia” that will shed light on the latest in HPV scientific research.
The EUROGIN congress offers a full overview of current scientific developments in the field of cervical cancer and other HPV related diseases control with a program informed by leading scientists.